Chase Nicker-Bucker
Analyst at Craig Helium
Replay available
Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Swayam Pakola
Analyst at H.C. Wainwright
Madison El-Sadi
Analyst at B-Wyly Securities
Sean Brangelson
Chief Executive Officer
David Krempa
Head of Investor Relations
James Gruber
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:03.820 Thank you for standing by. My name is Alex and I will be your conference operator for 00:00:03.820 -- 00:00:09.460 today. At this time, I would like to welcome everyone to the ATON Pharmaceutical Q2 2025 00:00:09.460 -- 00:00:14.060 earnings call. All lines have been placed on mute to prevent any background noise. 00:00:14.060 -- 00:00:17.980 After the speaker's remarks, there will be a question and answer session. 00:00:17.980 -- 00:00:22.200 If you would like to ask a question during this time, simply press star followed by the 00:00:22.200 -- 00:00:26.900 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:26.900 -- 00:00:31.360 star one again. Thank you. I would now like to turn the call over to Mr. 00:00:31.360 -- 00:00:34.840 David Krempa. Please go ahead. 00:00:35.840 -- 00:00:39.020 Thank you, operator. Good afternoon, everyone, and welcome 00:00:39.020 -- 00:00:42.980 to EATON second quarter 2025 conference call. 00:00:42.980 -- 00:00:47.260 This afternoon, we issued a press release that outlines the topics we plan to discuss 00:00:47.260 -- 00:00:49.180 on today's 00:00:49.180 -- 00:00:53.680 call. The release is available on our website, eatonpharma.com. 00:00:53.880 -- 00:00:59.160 Joining me on our call today, we have Sean Brangelson, our CEO, James Gruber, 00:00:59.160 -- 00:01:04.340 our CFO, and Epek Trinkas, our chief commercial officer. 00:01:04.340 -- 00:01:08.480 In addition to taking live questions on the call today, we will be answering questions 00:01:08.480 -- 00:01:15.320 that are emailed to us. Investors can send their questions to investorrelations at eatonpharma.com. 00:01:15.480 -- 00:01:20.160 Before we begin, I would like to remind everyone that remarks made d...